Trevena Inc is a clinical stage biopharmaceutical company involved in the discovery and development of G-protein coupled receptors (GPCR) biased ligands. The Company's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects. Trevena’s pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and discovery-stage programs for chronic pain, migraine, and Parkinson’s disease.

Company Growth (employees)
Type
Public
HQ
King Of Prussia, US
Founded
2008
Size (employees)
72 (est)
Trevena was founded in 2008 and is headquartered in King of Prussia, US

Trevena Office Locations

Trevena has an office in King of Prussia
King of Prussia, US (HQ)
1018 West 8th Avenue

Trevena Financials and Metrics

Trevena Financials

Trevena's revenue was reported to be $3.8 m in FY, 2016
USD

Net income (Q1, 2017)

(20.7 m)

Market capitalization (13-Nov-2017)

94.4 m

Cash (30-Jun-2017)

14 m
Trevena's current market capitalization is $94.4 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

6.3 m3.8 m

Revenue growth, %

(40%)

Net Income

(49.7 m)(50.5 m)(103 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(20.9 m)(36.4 m)(12.9 m)(24.4 m)(35.1 m)(17.8 m)(37 m)(66.9 m)(20.7 m)
USDFY, 2014FY, 2015FY, 2016

Cash

36.2 m46.8 m24.3 m

Accounts Receivable

4.1 m

Inventories

669.2 k1.9 m1.8 m

Current Assets

107.6 m174.5 m112.4 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

81.6 m72.2 m29.1 m43.7 m39 m34.5 m36.8 m25.2 m18.7 m14 m

Current Assets

84.2 m73.1 m102.5 m107.3 m170 m166 m147.6 m121.3 m100.8 m87.7 m

PP&E

392.3 k594 k590.2 k609.3 k601.5 k823.5 k807.4 k745.3 k1.1 m2.9 m

Total Assets

84.7 m74 m103.2 m108 m170.7 m166.9 m148.6 m122.1 m103.1 m92 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(49.7 m)(50.5 m)(103 m)

Depreciation and Amortization

239.4 k207.9 k246 k

Accounts Receivable

(10.7 m)(17.5 m)

Inventories

(2.9 m)(2.8 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(20.9 m)(36.4 m)(12.9 m)(24.4 m)(35.1 m)(17.8 m)(37 m)(66.9 m)(20.7 m)(41.1 m)

Depreciation and Amortization

142.1 k184.9 k52.5 k104.5 k155.3 k57.5 k118.5 k180 k79 k158 k

Accounts Payable

(2.4 m)(1.3 m)(1.9 m)(2.2 m)(1.1 m)620.8 k(9.9 m)

Cash From Operating Activities

(15.8 m)(26.7 m)(6 m)(16.3 m)(28.2 m)(20.6 m)(39.2 m)(63.9 m)(29.5 m)(47.7 m)
Y, 2017

Financial Leverage

1.7 x
Show all financial metrics

Trevena Market Value History

Trevena's Web-traffic and Trends

Trevena Company Life and Culture

You may also be interested in